recently been enhanced through him being awarded a Royal Society Industry Fellowship to collaborate with AstraZeneca

She trained in pharmacology at McGill University with Paul Clarke and completed postdoctoral work at AstraZeneca Her next career step took her to AstraZeneca as a postdoctoral trainee, where she studied animal models

initiated and identified the lead mAb for the type I interferon-alpha receptor project, licensed to AstraZeneca